The European Commission has recently given the green light to two major joint projects in the European Union, one in the hydrogen sector and the other in healthcare. The hydrogen project, funded by Estonia, France, Germany, Italy, Netherlands, Slovakia, and Spain, amounts to 1.4 billion euros in public funding and is anticipated to leverage an additional 3.3 billion euros in private investments. This initiative involves the participation of 11 companies, including notable names like Airbus, BMW, and Michelin, across 13 projects. On the healthcare front, a separate 1 billion euro project, supported by Belgium, France, Hungary, Italy, Slovakia, and Spain, is aimed at promoting research and innovation. This healthcare project is projected to unlock 5.9 billion euros in private investments and will engage companies such as Sanofi, Euroapi, and others in 14 healthcare schemes. Both projects fall under the Important Projects of Common European Interest (IPCEI) framework, enabling EU governments to provide funding while adhering to more flexible state aid regulations. These initiatives not only attract significant public and private investments but also foster collaboration among leading companies to drive advancement in the hydrogen and healthcare sectors.